Fact CheckerSign in

NCT04379999CompletedEarly phase 1

Atorvastatin ± Aspirin in Lynch Syndrome Syndrome

Impact of Atorvastatin ± Aspirin on Colorectal Biomarkers in Patients With Lynch Syndrome: a Pilot Study

Source: ClinicalTrials.gov · Last updated 7 Aug 2025

Brief summary (registry, in English)

The goal of this study is to investigate that a common cholesterol lowering agent (atorvastatin) alone or combining with a nonsteroidal anti-inflammatory drug (aspirin) would reduce the risk of colorectal cancer (CRC) in high-risk individuals with Lynch syndrome.

Status (registry)
Completed
Phase (registry)
Early phase 1
Study type
Interventional
Enrollment
43 (actual)
First submitted
3 Jan 2020
Start date
10 Sept 2018
Primary completion date
4 Aug 2025
Lead sponsor
Fox Chase Cancer Center
NCT number
NCT04379999

What you commit to

  • Study type: Interventional · Early phase 1
  • Participants enrolled: 43
  • From 10 Sept 2018 to the primary completion date, 4 Aug 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Have active cancer or are less than 3 years post hormonal maintenance therapy for cancer

Age

  • Are \<18 years of age

Other

  • Unable to read and sign an informed consent document in English
  • Have statin intolerance or contraindication for aspirin or atorvastatin use
  • Are pregnant or are actively breast feeding

Who the study is looking for

  • Subjects who are 18 years of age or older
  • Able to read and sign an informed consent document in English
  • Eligible subjects will have molecular evidence of Lynch Syndrome (mutation in MLH1, MSH2, MSH6, EPCAM or PMS2)
  • History of colorectal cancer if surgically cured and \> 1 year from completion of adjuvant chemotherapy

Age in the registry: 18 years to 75 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Fox Chase Cancer Center
Coordinator of this site? Confirm its status
PhiladelphiaUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.